Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

686 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A Pragmatic, Randomized Controlled Trial of Oral Antivirals for the Treatment of Chronic Hepatitis C: The PRIORITIZE Study.
Sulkowski MS, Moon JS, Sherman KE, Morelli G, Darling JM, Muir AJ, Khalili M, Fishbein DA, Hinestrosa F, Shiffman ML, Di Bisceglie A, Rajender Reddy K, Pearlman B, Lok AS, Fried MW, Stewart PW, Peter J, Wadsworth S, Kixmiller S, Sloan A, Vainorius M, Horne PM, Michael L, Dong M, Evon DM, Segal JB, Nelson DR; PRIORITIZE Study Team. Sulkowski MS, et al. Among authors: sloan a. Hepatology. 2021 Dec;74(6):2952-2964. doi: 10.1002/hep.32053. Epub 2021 Aug 26. Hepatology. 2021. PMID: 34255381 Free PMC article. Clinical Trial.
Experiences of an HCV Patient engagement group: a seven-year journey.
UNC Chapel Hill HCV Patient Engagement Group; Kixmiller S, Sloan AP, Wadsworth S, Brown F, Chaney L, Houston L, Thomas K. UNC Chapel Hill HCV Patient Engagement Group, et al. Res Involv Engagem. 2021 Jan 25;7(1):7. doi: 10.1186/s40900-021-00249-2. Res Involv Engagem. 2021. PMID: 33494839 Free PMC article. Review.
VTE incidence shortens survival in IDH-WT glioblastoma.
Sloan AR, Gordillo AJ, Kennemer A, Khorana AA, Horbinski C, Kaelber DC, Cameron SJ, Lathia JD. Sloan AR, et al. medRxiv [Preprint]. 2025 Jan 9:2025.01.08.25319908. doi: 10.1101/2025.01.08.25319908. medRxiv. 2025. PMID: 39830282 Free PMC article. Preprint.
Efficacy, safety, and target engagement of dazukibart, an IFNβ specific monoclonal antibody, in adults with dermatomyositis: a multicentre, double-blind, randomised, placebo-controlled, phase 2 trial.
Fiorentino D, Mangold AR, Werth VP, Christopher-Stine L, Femia A, Chu M, Musiek ACM, Sluzevich JC, Graham LV, Fernandez AP, Aggarwal R, Rieger K, Page KM, Li X, Hyde C, Rath N, Sloan A, Oemar B, Banerjee A, Salganik M, Banfield C, Neelakantan S, Beebe JS, Vincent MS, Peeva E, Vleugels RA. Fiorentino D, et al. Among authors: sloan a. Lancet. 2025 Jan 11;405(10473):137-146. doi: 10.1016/S0140-6736(24)02071-3. Lancet. 2025. PMID: 39798982 Clinical Trial.
Development and validation of a molecular classifier of meningiomas.
Landry AP, Wang JZ, Liu J, Patil V, Gui C, Patel Z, Ajisebutu A, Ellenbogen Y, Wei Q, Singh O, Sosa J, Mansouri S, Wilson C, Cohen-Gadol AA, Zaazoue MA, Tabatabai G, Tatagiba M, Behling F, Barnholtz-Sloan JS, Sloan AE, Chotai S, Chambless LB, Rebchuk AD, Makarenko S, Yip S, Mansouri A, Tsang DS, Aldape K, Gao A; International Consortium on Meningiomas (ICOM); Nassiri F, Zadeh G. Landry AP, et al. Among authors: sloan ae. Neuro Oncol. 2025 Jan 8:noae242. doi: 10.1093/neuonc/noae242. Online ahead of print. Neuro Oncol. 2025. PMID: 39775867
Ezetimibe Enhances Lipid Droplet and Mitochondria Contact Formation, Improving Fatty Acid Transfer and Reducing Lipotoxicity in Alport Syndrome Podocytes.
Kim JJ, Yang EJ, Molina David J, Cho S, Ficarella M, Pape N, Schiffer JE, Njeim R, Kim SS, Lo Re C, Fontanella A, Kaber M, Sloan A, Merscher S, Fornoni A. Kim JJ, et al. Among authors: sloan a. Int J Mol Sci. 2024 Dec 6;25(23):13134. doi: 10.3390/ijms252313134. Int J Mol Sci. 2024. PMID: 39684843 Free PMC article.
Machine Learning-based Prognostic Subgrouping of Glioblastoma: A Multi-center Study.
Akbari H, Bakas S, Sako C, Fathi Kazerooni A, Villanueva-Meyer J, Garcia JA, Mamourian E, Liu F, Cao Q, Shinohara RT, Baid U, Getka A, Pati S, Singh A, Calabrese E, Chang S, Rudie J, Sotiras A, LaMontagne P, Marcus DS, Milchenko M, Nazeri A, Balana C, Capellades J, Puig J, Badve C, Barnholtz-Sloan JS, Sloan AE, Vadmal V, Waite K, Ak M, Colen RR, Park YW, Ahn SS, Chang JH, Choi YS, Lee SK, Alexander GS, Ali AS, Dicker AP, Flanders AE, Liem S, Lombardo J, Shi W, Shukla G, Griffith B, Poisson LM, Rogers LR, Kotrotsou A, Booth TC, Jain R, Lee M, Mahajan A, Chakravarti A, Palmer JD, DiCostanzo D, Fathallah-Shaykh H, Cepeda S, Santonocito OS, Di Stefano AL, Wiestler B, Melhem ER, Woodworth GF, Tiwari P, Valdes P, Matsumoto Y, Otani Y, Imoto R, Aboian M, Koizumi S, Kurozumi K, Kawakatsu T, Alexander K, Satgunaseelan L, Rulseh AM, Bagley SJ, Bilello M, Binder ZA, Brem S, Desai AS, Lustig RA, Maloney E, Prior T, Amankulor N, Nasrallah MLP, O'Rourke DM, Mohan S, Davatzikos C; ReSPOND consortium. Akbari H, et al. Among authors: sloan ae. Neuro Oncol. 2024 Dec 12:noae260. doi: 10.1093/neuonc/noae260. Online ahead of print. Neuro Oncol. 2024. PMID: 39665363
686 results